Global apoptosis assays market is anticipated to value around 4.7 billion by 2026 end and register a CAGR of over 9.4% from the forecast period 2019-2026.
Increasing prevalence of chronic diseases and infections coupled with the latest development in apoptosis modulating drugs is driving the market. Funds raised by governments for cancer research is further fueling the apoptosis assays market growth.
The market is bifurcated into by product, by detection technology, by application, by end-user and region. In terms of product, assay kits are expected to dominate the market growth. The ability of Annexin V and cell permeability assays to bind phosphatidylserine alongside its usage in various applications like drug discovery and development and scientific research is leading to an increase in the demand of assay kits, thus propelling the apoptosis assays market growth.
In terms of detection technology, cell imaging and microscopy is the front runner of the market owing to its ability to monitor cell physiology. Besides, it also examines complex cellular processes and owing to these features there has been a huge demand for cell imaging and microscopy, thus stimulating the market.
Based on application, drug discovery and development holds a major share of the market. The increasing prevalence and incidence of infections and chronic diseases are driving the demand for drug discovery and development. The increasing research and development activities coupled with government efforts for developing new treatments for multiple diseases is bolstering the market.
Based on end-users, pharmaceutical and biotechnology companies are expected to drive the market growth. Increasing research and development activities and growing interest in the development of apoptosis targeted therapies is fueling the growth of the market.
North America dictates the market growth. Presence of high-quality infrastructure and prominent players is strengthening the market position in the region. Moreover, rising cases of chronic diseases and an increase in government funding for research and development activities are accelerating the market growth in the region. Furthermore, an ample presence of laboratory research centres remains a major factor for the expansion of the apoptosis assays market size.
Asia-Pacific region is expected to witness exponential growth due to the presence of a large patient population and increase in the spending on healthcare sector. China and India offer low-cost manufacturing services hence they are considered profitable manufacturing regions. Owing to low-cost manufacturing advantages, prominent players are trying to penetrate these regions.
Prominent players of the market are Danaher Corporation, BioTek Instruments, Promega Corporation, PerkinElmer, Abcam plc, Abnova, Creative Bioarray, Thermo Fisher Scientific, Merck KgaA, Becton, GE Healthcare, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius.
Competitive Landscape:
· Merck acquired Sigma Aldrich Corporation. The move helped Merck to strengthen its life science segment
· Thermo Fisher Scientific in 2018, launched Multiskan Sky Microplate Spectrophotometer
· Dickinson and Company and Becton in 2017 acquired C.R Bard
Global Apoptosis Assays Market Segmentation:
By Product
? Assay Kits
? Caspase Assays
? Annexin V and Cell Permeability Assays
? DNA Fragmentation Assay
? Mitochondrial Assays
? Reagents
? Microplates
? Instruments
By Detection Technology
? Flow Cytometry
? Cell Imaging & Analysis Systems
? Spectrophotometry
? Other Detection Technologies
By Application
? Basic Research
? Clinical & Diagnostic Applications
? Drug Discovery & Development
? Stem Cell Research
By End-User
? Hospital and Diagnostic Laboratories
? Pharmaceutical and Biotechnology Companies
? Academic and Research Institutes
By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Rest of the World
FutureWise Key Takeaways:
? Growth Prospects
? SWOT Analysis
? Key Trends
? Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the apoptosis market by product, by detection technology, by application, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• Evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com